• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清生物标志物对非B、非C型肝细胞癌根治性切除患者的诊断价值

Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.

作者信息

Li Youdi, Chen Yanfei, Chen Jiu

机构信息

Department of Traditional Chinese Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

J Coll Physicians Surg Pak. 2020 Feb;30(2):134-138. doi: 10.29271/jcpsp.2020.02.134.

DOI:10.29271/jcpsp.2020.02.134
PMID:32036818
Abstract

OBJECTIVE

To determine the diagnostic value of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for patients with non-B, non-C hepatocellular carcinoma (NBNC HCC).

STUDY DESIGN

Observational study.

PLACE AND DURATION OF STUDY

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China, from June 2016 to June 2019.

METHODOLOGY

Patients with NBNC HCC diagnosed by histology were inducted after curative resection. Serum levels of AFP and DCP were determined. Their receiver operating characteristic (ROC) curves were generated, and the area under the ROC curve (AUC) calculated. In subgroup analyses involving patients with hepatitis B core antibody (HBcAb) testing, the AUC of AFP and DCP were also calculated and compared.

RESULTS

Serum levels of AFP and DCP were clearly increased in the NBNC HCC group relative to controls (p = 0.000 for both). The AUC for AFP, DCP and their combination (AFP+DCP) were 0.763 (95%CI: 0.712-0.814), 0.853 (95%CI: 0.811-0.894), and 0.867 (95%CI: 0.829-0.906), respectively. For HBcAb-positivity, the AUC of AFP and DCP were 0.7517 (95%CI: 0.6917-0.8116) and 0.8469 (95% CI: 0.7985-0.8963), respectively. For HBcAb-negativity, the AUC of AFP and DCP were 0.8083 (95%CI: 0.6993-0.9174) and 0.8740 (95%CI: 0.7901-0.9580), respectively.

CONCLUSION

A combination of AFP and DCP is useful for assisting the diagnosis of NBNC HCC before surgery. AFP and DCP showed better diagnostic accuracy for HBcAb-negativity compared with HBcAb-positivity in NBNC HCC patients.

摘要

目的

确定甲胎蛋白(AFP)和异常凝血酶原(DCP)对非B、非C型肝细胞癌(NBNC HCC)患者的诊断价值。

研究设计

观察性研究。

研究地点和时间

2016年6月至2019年6月,中国杭州浙江大学医学院附属第一医院。

方法

对经组织学诊断为NBNC HCC的患者进行根治性切除术后纳入研究。测定血清AFP和DCP水平。绘制其受试者工作特征(ROC)曲线,并计算ROC曲线下面积(AUC)。在涉及乙肝核心抗体(HBcAb)检测患者的亚组分析中,也计算并比较了AFP和DCP的AUC。

结果

与对照组相比,NBNC HCC组血清AFP和DCP水平明显升高(两者p = 0.000)。AFP、DCP及其联合检测(AFP + DCP)的AUC分别为0.763(95%CI:0.712 - 0.814)、0.853(95%CI:0.811 - 0.894)和0.867(95%CI:0.829 - 0.906)。对于HBcAb阳性患者,AFP和DCP的AUC分别为0.7517(95%CI:0.6917 - 0.8116)和0.8469(95%CI:0.7985 - 0.8963)。对于HBcAb阴性患者,AFP和DCP的AUC分别为0.8083(95%CI:0.6993 - 0.9174)和0.8740(95%CI:0.7901 - 0.9580)。

结论

AFP和DCP联合检测有助于术前诊断NBNC HCC。在NBNC HCC患者中,与HBcAb阳性相比,AFP和DCP对HBcAb阴性患者显示出更好的诊断准确性。

相似文献

1
Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.血清生物标志物对非B、非C型肝细胞癌根治性切除患者的诊断价值
J Coll Physicians Surg Pak. 2020 Feb;30(2):134-138. doi: 10.29271/jcpsp.2020.02.134.
2
Diagnostic Value of Serum Biomarkers in Combined Hepatocelluar-Cholangiocarcinoma.血清生物标志物在肝细胞胆管细胞癌中的诊断价值。
J Coll Physicians Surg Pak. 2020 Mar;30(3):263-267. doi: 10.29271/jcpsp.2020.03.263.
3
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.在中国,去γ-羧基凝血酶原与甲胎蛋白对乙型肝炎病毒相关肝细胞癌的诊断评估:一项大规模、多中心研究
PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016.
4
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.甲胎蛋白与异常凝血酶原联合检测在中国肝细胞癌患者诊断中的临床应用:一项针对1153名受试者的多中心病例对照研究
Biosci Trends. 2014 Oct;8(5):266-73. doi: 10.5582/bst.2014.01116.
5
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.甲胎蛋白和去γ-羧基凝血酶原在接受肝切除术的肝细胞癌患者中的意义。
Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.
6
Serum Des-gamma-carboxy Prothrombin for Diagnosis of Adult Primary Cancer in Liver.血清去γ-羧基凝血酶原用于成人原发性肝癌的诊断
J Coll Physicians Surg Pak. 2019 Oct;29(10):972-976. doi: 10.29271/jcpsp.2019.10.972.
7
Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse G600 analyzer.在法国队列中使用Lumipulse G600分析仪检测去γ-羧基凝血酶原对肝细胞癌的诊断准确性
J Viral Hepat. 2017 Jan;24(1):80-85. doi: 10.1111/jvh.12622. Epub 2016 Oct 4.
8
Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma.血清去γ-羧基凝血酶原在肝细胞癌检测中的应用价值。
World J Gastroenterol. 2005 Oct 21;11(39):6115-9. doi: 10.3748/wjg.v11.i39.6115.
9
Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.去γ-羧基凝血酶原和甲胎蛋白阳性状态作为肝细胞癌肝切除术后新的预后指标
Cancer. 1996 Nov 15;78(10):2094-100. doi: 10.1002/(sici)1097-0142(19961115)78:10<2094::aid-cncr9>3.0.co;2-o.
10
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.

引用本文的文献

1
The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinoma.甲胎蛋白和异常凝血酶原模型对非乙型肝炎非丙型肝炎肝细胞癌的诊断性能。
BMC Res Notes. 2023 Nov 6;16(1):317. doi: 10.1186/s13104-023-06600-y.
2
Clinical characteristics, prognosis, and surgical outcomes of patients with non-HBV and non-HCV related hepatocellular carcinoma: three-decade observational study.非乙型肝炎和非丙型肝炎相关肝细胞癌患者的临床特征、预后和手术治疗结果:一项长达三十年的观察性研究。
BMC Gastroenterol. 2023 Jun 8;23(1):200. doi: 10.1186/s12876-023-02833-0.